J. Kamradt

Prospective randomized double‐blind multicentre phase <scp>II</scp> study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: <scp>SUSE</scp> ( <scp>AUO‐AB</scp> 31/05)

S. Krege, Heidrun Rexer, F. vom Dorp et al. · British Journal of Urology · 2013 · 68 citations

Outcome of Prostate Cancer Patients with Initial PSA ≥ 20 ng/ml Undergoing Radical Prostatectomy

Ulrike Zwergel, H. Suttmann, Thomas Schroeder et al. · European Urology · 2007 · 42 citations

Urology, Surgical Oncology, Genitourinary Cancer +6

Detection of Novel Amplicons in Prostate Cancer by Comprehensive Genomic Profiling of Prostate Cancer Cell Lines Using Oligonucleotide-Based ArrayCGH

J. Kamradt, Volker Jung, Kerstin Wahrheit et al. · PLoS ONE · 2007 · 39 citations · Full text

Telomerase Activity and Telomerase Subunit Gene Expression Levels Are Not Related in Prostate Cancer: A Real-Time Quantification and In Situ Hybridization Study

J. Kamradt, Carsten Drosse, Sascha Kalkbrenner et al. · Laboratory Investigation · 2003 · 31 citations

Urology, Genitourinary Cancer, Medicine +6

Evidence for gains at 15q and 20q in brain metastases of prostate cancer

Bernd Wullich, Silke Riedinger, Ulrich Brinck et al. · Cancer Genetics and Cytogenetics · 2004 · 15 citations

Neuro-oncology, Urology, Brain Metastases +5